Overview

Tranexamic Acid in Cyanotic Heart Defects

Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The use of antifibrinolytic agents such as to reduce blood loss in congenital cardiac surgery has been described in many studies
Phase:
Phase 2
Details
Lead Sponsor:
Assiut University
Treatments:
Tranexamic Acid